ChengDa PharmaCeuticals Co., Ltd. Class A

ChengDa PharmaCeuticals Co., Ltd. Class A

SSZSE:301201
21.16
CNY
-0.54
(-2.49%)
-0.27EPS
4.72BMarket Cap

Latest Stock Split

Jul 07, 2023

8:5

For every 5 shares held, investors received 8. The price per share adjusted from $41.74 to $26.09.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jul 07, 2023
    Before$41.74
    Split ratio8:5
    After$26.09
    Forward

About ChengDa PharmaCeuticals Co., Ltd. Class A stock splits

ChengDa PharmaCeuticals Co., Ltd. Class A (SZSE:301201) operates in the Pharmaceuticals: major industry.

ChengDa PharmaCeuticals Co., Ltd. Class A company overview

When did ChengDa PharmaCeuticals Co., Ltd. Class A stock split?

ChengDa PharmaCeuticals Co., Ltd. Class A's most recent stock split was on July 7, 2023. It was a 8-for-5 forward split, so shareholders received 8 shares for every 5 they held.

How many times has ChengDa PharmaCeuticals Co., Ltd. Class A stock split?

ChengDa PharmaCeuticals Co., Ltd. Class A has split its stock once. This history records one forward split, on July 7, 2023.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In ChengDa PharmaCeuticals Co., Ltd. Class A's 8-for-5 split on July 7, 2023, every 5 shares became 8 shares.

Will ChengDa PharmaCeuticals Co., Ltd. Class A split its stock again?

ChengDa PharmaCeuticals Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on July 7, 2023, 3 years ago. Companies announce splits in advance, and any new SZSE:301201 split will appear on this page.